IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v13y2022i1d10.1038_s41467-022-33493-5.html
   My bibliography  Save this article

Hepatocyte phosphatase DUSP22 mitigates NASH-HCC progression by targeting FAK

Author

Listed:
  • Chenxu Ge

    (Chongqing University of Education
    Chongqing University
    Chongqing University of Education)

  • Jun Tan

    (Chongqing University of Education
    Chongqing University of Education)

  • Xianling Dai

    (Chongqing University of Education
    Chongqing University)

  • Qin Kuang

    (Chongqing University of Education
    Chongqing University)

  • Shaoyu Zhong

    (Chongqing University of Education
    Chongqing University of Education)

  • Lili Lai

    (Chongqing University of Education
    Chongqing University of Education)

  • Chao Yi

    (Chongqing University of Education
    Chongqing University of Education)

  • Yan Sun

    (Chongqing University of Education
    Chongqing University)

  • Jing Luo

    (Chongqing University of Education)

  • Chufeng Zhang

    (Shandong First Medical University & Shandong Academy of Medical Sciences)

  • Liancai Zhu

    (Chongqing University)

  • Bochu Wang

    (Chongqing University)

  • Minxuan Xu

    (Chongqing University of Education
    Chongqing University
    Chongqing University of Education)

Abstract

Nonalcoholic steatohepatitis (NASH), a common clinical disease, is becoming a leading cause of hepatocellular carcinoma (HCC). Dual specificity phosphatase 22 (DUSP22, also known as JKAP or JSP-1) expressed in numerous tissues plays essential biological functions in immune responses and tumor growth. However, the effects of DUSP22 on NASH still remain unknown. Here, we find a significant decrease of DUSP22 expression in human and murine fatty liver, which is mediated by reactive oxygen species (ROS) generation. Hepatic-specific DUSP22 deletion particularly exacerbates lipid deposition, inflammatory response and fibrosis in liver, facilitating NASH and non-alcoholic fatty liver disease (NAFLD)-associated HCC progression. In contrast, transgenic over-expression, lentivirus or adeno-associated virus (AAV)-mediated DUSP22 gene therapy substantially inhibit NASH-related phenotypes and HCC development in mice. We provide mechanistic evidence that DUSP22 directly interacts with focal adhesion kinase (FAK) and restrains its phosphorylation at Tyr397 (Y397) and Y576 + Y577 residues, subsequently prohibiting downstream activation of extracellular signal-regulated kinase 1/2 (ERK1/2) and nuclear factor-κB (NF-κB) cascades. The binding of DUSP22 to FAK and the dephosphorylation of FAK are indispensable for DUSP22-meliorated NASH progression. Collectively, our findings identify DUSP22 as a key suppressor of NASH-HCC, and underscore the DUSP22-FAK axis as a promising therapeutic target for treatment of the disease.

Suggested Citation

  • Chenxu Ge & Jun Tan & Xianling Dai & Qin Kuang & Shaoyu Zhong & Lili Lai & Chao Yi & Yan Sun & Jing Luo & Chufeng Zhang & Liancai Zhu & Bochu Wang & Minxuan Xu, 2022. "Hepatocyte phosphatase DUSP22 mitigates NASH-HCC progression by targeting FAK," Nature Communications, Nature, vol. 13(1), pages 1-21, December.
  • Handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-33493-5
    DOI: 10.1038/s41467-022-33493-5
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-022-33493-5
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-022-33493-5?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Minxuan Xu & Jun Tan & Wei Dong & Benkui Zou & Xuepeng Teng & Liancai Zhu & Chenxu Ge & Xianling Dai & Qin Kuang & Shaoyu Zhong & Lili Lai & Chao Yi & Tingting Tang & Junjie Zhao & Longyan Wang & Jin , 2022. "The E3 ubiquitin-protein ligase Trim31 alleviates non-alcoholic fatty liver disease by targeting Rhbdf2 in mouse hepatocytes," Nature Communications, Nature, vol. 13(1), pages 1-20, December.
    2. Ju-Pi Li & Chia-Yu Yang & Huai-Chia Chuang & Joung-Liang Lan & Der-Yuan Chen & Yi-Ming Chen & Xiaohong Wang & Alice J. Chen & John W. Belmont & Tse-Hua Tan, 2014. "The phosphatase JKAP/DUSP22 inhibits T-cell receptor signalling and autoimmunity by inactivating Lck," Nature Communications, Nature, vol. 5(1), pages 1-13, May.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Qilun Zhang & Xuting Shen & Xin Yuan & Jing Huang & Yaling Zhu & Tengteng Zhu & Tao Zhang & Haibo Wu & Qian Wu & Yinguang Fan & Jing Ni & Leilei Meng & Anyuan He & Chaowei Shi & Hao Li & Qingsong Hu &, 2024. "Lipopolysaccharide binding protein resists hepatic oxidative stress by regulating lipid droplet homeostasis," Nature Communications, Nature, vol. 15(1), pages 1-17, December.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Minxuan Xu & Jun Tan & Xin Liu & Li Han & Chenxu Ge & Yujie Zhang & Fufang Luo & Zhongqin Wang & Xiaoqin Xue & Liangyin Xiong & Xin Wang & Qinqin Zhang & Xiaoxin Wang & Qin Tian & Shuguang Zhang & Qin, 2023. "Tripartite motif containing 26 prevents steatohepatitis progression by suppressing C/EBPδ signalling activation," Nature Communications, Nature, vol. 14(1), pages 1-22, December.
    2. Ying-Chun Shih & Hsueh-Fen Chen & Chia-Ying Wu & Yi-Ru Ciou & Chia-Wen Wang & Huai-Chia Chuang & Tse-Hua Tan, 2024. "The phosphatase DUSP22 inhibits UBR2-mediated K63-ubiquitination and activation of Lck downstream of TCR signalling," Nature Communications, Nature, vol. 15(1), pages 1-21, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:13:y:2022:i:1:d:10.1038_s41467-022-33493-5. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.